Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    November 2019
  1. VOELKER R
    Study Identifies Primary Care Knowledge Gaps and Barriers in Type 2 Diabetes Prevention.
    JAMA. 2019 Nov 6. pii: 2755345. doi: 10.1001/jama.2019.18024.
    PubMed     Text format    


    October 2019
  2. SLOMSKI A
    Diabetes, Prior PCI, and Dual Antiplatelet Therapy.
    JAMA. 2019;322:1544.
    PubMed     Text format    


  3. WILLIAMS J, Loeffler M
    Global Trends in Type 2 Diabetes, 2007-2017.
    JAMA. 2019;322:1542.
    PubMed     Text format    


  4. GREGG EW, Hora I, Benoit S
    Reasons for Increases in Complications of Diabetes-Reply.
    JAMA. 2019;322:1519.
    PubMed     Text format    


  5. BUSE JB
    Reasons for Increases in Complications of Diabetes.
    JAMA. 2019;322:1518-1519.
    PubMed     Text format    


  6. NOTLEY SR, Poirier MP, Sigal RJ, D'Souza A, et al
    Exercise Heat Stress in Patients With and Without Type 2 Diabetes.
    JAMA. 2019;322:1409-1411.
    PubMed     Text format    


  7. FLORY J, Lipska K
    Metformin for Type 2 Diabetes-Reply.
    JAMA. 2019;322:1313.
    PubMed     Text format    


  8. PATEL JJ, Mundi MS
    Metformin for Type 2 Diabetes.
    JAMA. 2019;322:1312-1313.
    PubMed     Text format    


  9. CATURANO A, Galiero R, Pafundi PC
    Metformin for Type 2 Diabetes.
    JAMA. 2019;322:1312.
    PubMed     Text format    


  10. CHEN TK, Knicely DH, Grams ME
    Chronic Kidney Disease Diagnosis and Management: A Review.
    JAMA. 2019;322:1294-1304.
    PubMed     Text format     Abstract available


    September 2019
  11. MCCOY RG, Rodriguez-Gutierrez R
    Measuring the Quality of Diabetes Care-Reply.
    JAMA. 2019;322:1212-1213.
    PubMed     Text format    


  12. GIUGLIANO D, Maiorino MI, Esposito K
    Measuring the Quality of Diabetes Care.
    JAMA. 2019;322:1212.
    PubMed     Text format    


  13. ROUMIE CL, Chipman J, Min JY, Hackstadt AJ, et al
    Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function.
    JAMA. 2019 Sep 19:1-11. doi: 10.1001/jama.2019.13206.
    PubMed     Text format     Abstract available


  14. ROSENSTOCK J, Kahn SE, Johansen OE, Zinman B, et al
    Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
    JAMA. 2019 Sep 19. pii: 2751398. doi: 10.1001/jama.2019.13772.
    PubMed     Text format     Abstract available


  15. AMINIAN A, Zajichek A, Arterburn DE, Wolski KE, et al
    Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.
    JAMA. 2019 Sep 2. pii: 2749478. doi: 10.1001/jama.2019.14231.
    PubMed     Text format     Abstract available


  16. LIVINGSTON EH
    The Role of Bariatric Surgery in Managing the Macrovascular Complications of Obesity-Related Type 2 Diabetes.
    JAMA. 2019 Sep 2. pii: 2749475. doi: 10.1001/jama.2019.14577.
    PubMed     Text format    


    August 2019
  17. SLOMSKI A
    Vitamin D Doesn't Protect Against Diabetes.
    JAMA. 2019;322:717.
    PubMed     Text format    


  18. SHAH NS, Lloyd-Jones DM, O'Flaherty M, Capewell S, et al
    Trends in Cardiometabolic Mortality in the United States, 1999-2017.
    JAMA. 2019;322:780-782.
    PubMed     Text format    


  19. ABBASI J
    Type 1 Diabetes Advances Could Pave Way for Prevention.
    JAMA. 2019 Aug 21. pii: 2748913. doi: 10.1001/jama.2019.10432.
    PubMed     Text format    


  20. ANDREN ARONSSON C, Lee HS, Hard Af Segerstad EM, Uusitalo U, et al
    Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk.
    JAMA. 2019;322:514-523.
    PubMed     Text format     Abstract available


    July 2019
  21. KUEHN B
    Diabetes Incidence Decreases.
    JAMA. 2019;322:108.
    PubMed     Text format    


  22. SIMHA V, Shah P
    Glucose Control in the Perioperative Period-Reply.
    JAMA. 2019;322:82-83.
    PubMed     Text format    


  23. FINUCANE TE
    Glucose Control in the Perioperative Period.
    JAMA. 2019;322:82.
    PubMed     Text format    


    May 2019
  24. FLORY J, Lipska K
    Metformin in 2019.
    JAMA. 2019;321:1926-1927.
    PubMed     Text format    


  25. ALEXOPOULOS AS, Blair R, Peters AL
    Management of Preexisting Diabetes in Pregnancy: A Review.
    JAMA. 2019;321:1811-1819.
    PubMed     Text format     Abstract available



  26. Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes.
    JAMA. 2019;321:1720-1721.
    PubMed     Text format    


  27. VOERMAN E, Santos S, Inskip H, Amiano P, et al
    Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes.
    JAMA. 2019;321:1702-1715.
    PubMed     Text format     Abstract available


    April 2019
  28. CHEW EY
    Patients With Good Vision and Diabetic Macular Edema Involving the Center of the Macula: To Treat or Not to Treat?
    JAMA. 2019 Apr 29. pii: 2732607. doi: 10.1001/jama.2019.5793.
    PubMed     Text format    


  29. BAKER CW, Glassman AR, Beaulieu WT, Antoszyk AN, et al
    Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
    JAMA. 2019 Apr 29. pii: 2732608. doi: 10.1001/jama.2019.5790.
    PubMed     Text format     Abstract available


  30. LUM E, Jimenez G, Huang Z, Thai L, et al
    Decision Support and Alerts of Apps for Self-management of Blood Glucose for Type 2 Diabetes.
    JAMA. 2019;321:1530-1532.
    PubMed     Text format    


  31. HIRSCH IB
    The Future of the GLP-1 Receptor Agonists.
    JAMA. 2019;321:1457-1458.
    PubMed     Text format    


  32. RUBIN R
    Dr Schrier Goes to Congress as Second Woman Physician.
    JAMA. 2019;321:1443-1445.
    PubMed     Text format    


  33. GREGG EW, Hora I, Benoit SR
    Resurgence in Diabetes-Related Complications.
    JAMA. 2019 Apr 15. pii: 2730953. doi: 10.1001/jama.2019.3471.
    PubMed     Text format    


  34. RODRIGUEZ-GUTIERREZ R, McCoy RG
    Measuring What Matters in Diabetes.
    JAMA. 2019 Apr 15. pii: 2730954. doi: 10.1001/jama.2019.4310.
    PubMed     Text format    


    March 2019
  35. ROSENSTOCK J, Allison D, Birkenfeld AL, Blicher TM, et al
    Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial.
    JAMA. 2019 Mar 23. pii: 2729339. doi: 10.1001/jama.2019.2942.
    PubMed     Text format     Abstract available


  36. ABBASI J
    Quick Uptakes: After Rotavirus Vaccine, Australia's Type 1 Diabetes Incidence Declines.
    JAMA. 2019 Mar 13. pii: 2728577. doi: 10.1001/jama.2019.0766.
    PubMed     Text format    


  37. GLASSMAN AR
    Errors in Analysis of Mean Deviations in Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1007-1008.
    PubMed     Text format    



  38. Errors in Analysis of Study of Photocoagulation vs Ranibizumab for Diabetic Retinopathy.
    JAMA. 2019;321:1008.
    PubMed     Text format    


  39. BALDUCCI S, D'Errico V, Haxhi J, Sacchetti M, et al
    Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.
    JAMA. 2019;321:880-890.
    PubMed     Text format     Abstract available


    February 2019
  40. LOWE WL JR, Scholtens DM, Metzger BE
    Gestational Diabetes and Childhood Obesity-Reply.
    JAMA. 2019;321:708-709.
    PubMed     Text format    


  41. BRADSHAW JM, Ensor SJA, Lorenz HAL
    Gestational Diabetes and Childhood Obesity.
    JAMA. 2019;321:708.
    PubMed     Text format    


  42. SKIPPER N, Gaulke A, Sildorf SM, Eriksen TM, et al
    Association of Type 1 Diabetes With Standardized Test Scores of Danish Schoolchildren.
    JAMA. 2019;321:484-492.
    PubMed     Text format     Abstract available


    January 2019
  43. LUO J, Khan NF, Manetti T, Rose J, et al
    Implementation of a Health Plan Program for Switching From Analogue to Human Insulin and Glycemic Control Among Medicare Beneficiaries With Type 2 Diabetes.
    JAMA. 2019;321:374-384.
    PubMed     Text format     Abstract available


  44. LIPSKA KJ
    Insulin Analogues for Type 2 Diabetes.
    JAMA. 2019;321:350-351.
    PubMed     Text format    


  45. ZHENG SL, Roddick AJ
    Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    JAMA. 2019;321:277-287.
    PubMed     Text format     Abstract available


  46. NAGPAL SJS, Chari ST
    Immunoglobulin G4 Levels.
    JAMA. 2019;321:202-203.
    PubMed     Text format    


  47. SIMHA V, Shah P
    Perioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery.
    JAMA. 2019 Jan 7. pii: 2720429. doi: 10.1001/jama.2018.20922.
    PubMed     Text format    


  48. GRENNAN D
    Diabetic Foot Ulcers.
    JAMA. 2019;321:114.
    PubMed     Text format    


    December 2018
  49. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    PubMed     Text format     Abstract available


  50. SLOMSKI A
    Dual Receptor Agonist for Type 2 Diabetes.
    JAMA. 2018;320:2521.
    PubMed     Text format    


    November 2018
  51. TUNG EL, Davis AM, Laiteerapong N
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes-Reply.
    JAMA. 2018;320:1937-1938.
    PubMed     Text format    


  52. KANSAGARA D, Qaseem A, Wilt TJ
    Guidelines on Glycemic Targets for Persons With Type 2 Diabetes.
    JAMA. 2018;320:1937.
    PubMed     Text format    


  53. ROSENSTOCK J, Perkovic V, Johansen OE, Cooper ME, et al
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    JAMA. 2018 Nov 9. pii: 2714646. doi: 10.1001/jama.2018.18269.
    PubMed     Text format     Abstract available


    October 2018
  54. ABBASI J
    To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
    JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
    PubMed     Text format    


  55. FISHER DP, Johnson E, Haneuse S, Arterburn D, et al
    Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    JAMA. 2018;320:1570-1582.
    PubMed     Text format     Abstract available


  56. KING WC, Hinerman AS, Belle SH, Wahed AS, et al
    Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes.
    JAMA. 2018;320:1560-1569.
    PubMed     Text format     Abstract available


  57. SENAT MV, Affres H, Bouyer J
    Glyburide vs Insulin for Gestational Diabetes-Reply.
    JAMA. 2018;320:1384.
    PubMed     Text format    


  58. PENG S, Li C, Sun X
    Glyburide vs Insulin for Gestational Diabetes.
    JAMA. 2018;320:1383-1384.
    PubMed     Text format    


  59. OSPINA NS, Young WF Jr, Ghayee HK
    Diagnostic Testing for Elevated Cortisol in the Setting of an Adrenal Mass.
    JAMA. 2018;320:1373-1374.
    PubMed     Text format    


    September 2018
  60. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:1163-1171.
    PubMed     Text format     Abstract available


  61. LEBLANC ES, Patnode CD, Webber EM, Redmond N, et al
    Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;320:1172-1191.
    PubMed     Text format     Abstract available


  62. JIN J
    Behavioral Interventions for Weight Loss.
    JAMA. 2018;320:1210.
    PubMed     Text format    


  63. LOWE WL JR, Scholtens DM, Lowe LP, Kuang A, et al
    Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity.
    JAMA. 2018;320:1005-1016.
    PubMed     Text format     Abstract available


    August 2018
  64. ABBASI J
    Oral GLP-1 Analog for Type 2 Diabetes on the Horizon.
    JAMA. 2018;320:539.
    PubMed     Text format    


    June 2018
  65. RUBIN R
    Phone Apps for Patients With Diabetes.
    JAMA. 2018;319:2469.
    PubMed     Text format    


  66. XIANG AH, Wang X, Martinez MP, Page K, et al
    Maternal Type 1 Diabetes and Risk of Autism in Offspring.
    JAMA. 2018 Jun 23. pii: 2685775. doi: 10.1001/jama.2018.7614.
    PubMed     Text format    


  67. LIPSKA KJ, Parker MM, Moffet HH, Huang ES, et al
    Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    JAMA. 2018 Jun 23. pii: 2685850. doi: 10.1001/jama.2018.7993.
    PubMed     Text format     Abstract available


  68. CROWLEY MJ, Maciejewski ML
    Revisiting NPH Insulin for Type 2 Diabetes: Is a Step Back the Path Forward?
    JAMA. 2018 Jun 23. pii: 2685849. doi: 10.1001/jama.2018.8033.
    PubMed     Text format    



  69. Ertugliflozin for Type 2 Diabetes.
    JAMA. 2018;319:2434-2435.
    PubMed     Text format    


  70. TUNG EL, Davis AM, Laiteerapong N
    Glycemic Control in Nonpregnant Adults With Type 2 Diabetes.
    JAMA. 2018;319:2430-2431.
    PubMed     Text format    


    May 2018
  71. ABBASI J
    For Patients With Type 2 Diabetes, What's the Best Target Hemoglobin A1C?
    JAMA. 2018 May 30. pii: 2683543. doi: 10.1001/jama.2018.5420.
    PubMed     Text format    


  72. HEWITT DB, Barnard C, Bilimoria KY
    Improving Emergency Insulin Administration-Reply.
    JAMA. 2018;319:1937-1938.
    PubMed     Text format    


  73. SENAT MV, Affres H, Letourneau A, Coustols-Valat M, et al
    Effect of Glyburide vs Subcutaneous Insulin on Perinatal Complications Among Women With Gestational Diabetes: A Randomized Clinical Trial.
    JAMA. 2018;319:1773-1780.
    PubMed     Text format     Abstract available


  74. COUSTAN DR, Barbour L
    Insulin vs Glyburide for Gestational Diabetes.
    JAMA. 2018;319:1769-1770.
    PubMed     Text format    


    April 2018
  75. ZHENG SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, et al
    Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1580-1591.
    PubMed     Text format     Abstract available


  76. SHAPIRO AR
    Continuous Glucose Monitors for Insulin Dosing-Reply.
    JAMA. 2018;319:1384.
    PubMed     Text format    


  77. BECK RW
    Continuous Glucose Monitors for Insulin Dosing.
    JAMA. 2018;319:1383.
    PubMed     Text format    


    March 2018
  78. COGSWELL ME, Loria CM, Terry AL, Zhao L, et al
    Estimated 24-Hour Urinary Sodium and Potassium Excretion in US Adults.
    JAMA. 2018;319:1209-1220.
    PubMed     Text format     Abstract available


  79. DE BOER IH, Bakris G, Cannon CP
    Individualizing Blood Pressure Targets for People With Diabetes and Hypertension: Comparing the ADA and the ACC/AHA Recommendations.
    JAMA. 2018 Mar 15. pii: 2675563. doi: 10.1001/jama.2018.0642.
    PubMed     Text format    


    February 2018
  80. MOORE A, Derry S, Wiffen P
    Gabapentin for Chronic Neuropathic Pain.
    JAMA. 2018;319:818-819.
    PubMed     Text format     Abstract available


  81. VOELKER R
    Diabetic Foot Ulcers Heal With Shock Wave Therapy.
    JAMA. 2018;319:649.
    PubMed     Text format    


  82. SCHILLINGER D, Huey N
    Messengers of Truth and Health-Young Artists of Color Raise Their Voices to Prevent Diabetes.
    JAMA. 2018 Feb 14. pii: 2672777. doi: 10.1001/jama.2018.0986.
    PubMed     Text format    


  83. KARGES B, Binder E, Rosenbauer J
    Complications With Insulin Pump Therapy vs Insulin Injection Therapy-Reply.
    JAMA. 2018;319:503-504.
    PubMed     Text format    


    January 2018
  84. IKRAMUDDIN S, Korner J, Lee WJ, Thomas AJ, et al
    Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    JAMA. 2018;319:266-278.
    PubMed     Text format     Abstract available


  85. ABBASI J
    Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.
    JAMA. 2018;319:215-217.
    PubMed     Text format    


  86. JAKOBSEN GS, Smastuen MC, Sandbu R, Nordstrand N, et al
    Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities.
    JAMA. 2018;319:291-301.
    PubMed     Text format     Abstract available


  87. SALMINEN P, Helmio M, Ovaska J, Juuti A, et al
    Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    JAMA. 2018;319:241-254.
    PubMed     Text format     Abstract available


  88. SHUBECK S, Dimick JB, Telem DA
    Long-term Outcomes Following Bariatric Surgery.
    JAMA. 2018;319:302-303.
    PubMed     Text format    


  89. KNIP M, Akerblom HK, Al Taji E, Becker D, et al
    Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
    JAMA. 2018;319:38-48.
    PubMed     Text format     Abstract available


  90. HAMPTON T
    Smart Artificial Beta Cells May Help Treat Diabetes.
    JAMA. 2018;319:11-12.
    PubMed     Text format    


    December 2017
  91. BANCKS MP, Kershaw K, Carson AP, Gordon-Larsen P, et al
    Association of Modifiable Risk Factors in Young Adulthood With Racial Disparity in Incident Type 2 Diabetes During Middle Adulthood.
    JAMA. 2017;318:2457-2465.
    PubMed     Text format     Abstract available


  92. RIED-LARSEN M, Johansen MY, Pedersen BK
    Intensive Lifestyle Intervention for Type 2 Diabetes-Reply.
    JAMA. 2017;318:2494-2495.
    PubMed     Text format    


  93. GIUGLIANO D, Maiorino MI, Esposito K
    Intensive Lifestyle Intervention for Type 2 Diabetes.
    JAMA. 2017;318:2494.
    PubMed     Text format    


  94. TING DSW, Cheung CY, Lim G, Tan GSW, et al
    Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.
    JAMA. 2017;318:2211-2223.
    PubMed     Text format     Abstract available


    November 2017
  95. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  96. SLOMSKI A
    Continuous Glucose Monitoring in Pregnant Women With Diabetes.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  97. KRISCHER JP, Schatz DA, Bundy B, Skyler JS, et al
    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1891-1902.
    PubMed     Text format     Abstract available


  98. LANE W, Bailey TS, Gerety G
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes-Reply.
    JAMA. 2017;318:1828-1829.
    PubMed     Text format    


  99. ZULEWSKI H, Keller U
    Insulin Analogues and Hypoglycemia in Patients With Type 1 Diabetes.
    JAMA. 2017;318:1828.
    PubMed     Text format    


  100. SHAHRAZ S, Pittas AG, Saadati M, Thomas CP, et al
    Change in Testing, Awareness of Hemoglobin A1c Result, and Glycemic Control in US Adults, 2007-2014.
    JAMA. 2017;318:1825-1827.
    PubMed     Text format    


    October 2017
  101. SLOMSKI A
    Liraglutide May Reduce Diabetic Kidney Disease.
    JAMA. 2017;318:1532.
    PubMed     Text format    


  102. GAO P, Tang X, Hu Y
    Prediabetes Prevalence in China-Reply.
    JAMA. 2017;318:1612-1613.
    PubMed     Text format    


  103. FU N, Jiang Y, Sun W
    Prediabetes Prevalence in China.
    JAMA. 2017;318:1611-1612.
    PubMed     Text format    


  104. DAVIES M, Pieber TR, Hartoft-Nielsen ML, Hansen OKH, et al
    Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA. 2017;318:1460-1470.
    PubMed     Text format     Abstract available


  105. VOS RC, Rutten GEHM
    Oral Hypoglycemic Agents Added to Insulin Monotherapy for Type 2 Diabetes.
    JAMA. 2017;318:1489-1490.
    PubMed     Text format     Abstract available


  106. KARGES B, Schwandt A, Heidtmann B, Kordonouri O, et al
    Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    JAMA. 2017;318:1358-1366.
    PubMed     Text format     Abstract available


  107. HART T, Milner R, Cifu A
    Management of a Diabetic Foot.
    JAMA. 2017;318:1387-1388.
    PubMed     Text format    


    August 2017
  108. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: